Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OptimizeRx Corp | General Counsel and CCO | Common Stock | 27.2K | $129K | $4.75 | Dec 20, 2024 | Direct |
OptimizeRx Corp | General Counsel and CCO | Stock Option | 11.8K | $88.5K | $7.51 | Dec 19, 2023 | Direct |
OptimizeRx Corp | General Counsel and CCO | Restricted Stock Units | 7.86K | $84.1K | $10.70 | Dec 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OPRX | OptimizeRx Corp | Dec 19, 2024 | 3 | -$5.48K | 4 | Dec 20, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Nov 8, 2024 | 3 | -$3.29K | 4 | Nov 12, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Oct 3, 2024 | 3 | -$15.3K | 4 | Oct 7, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Mar 1, 2024 | 3 | -$4.27K | 4 | Mar 6, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Feb 15, 2024 | 1 | $0 | 4 | Apr 24, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Feb 11, 2024 | 3 | -$21.3K | 4 | Feb 13, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Jan 9, 2024 | 1 | -$60.8K | 4 | Jan 11, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Dec 19, 2023 | 2 | $0 | 4 | Feb 21, 2024 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Nov 8, 2023 | 3 | -$4.83K | 4 | Nov 13, 2023 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Oct 3, 2023 | 3 | -$13.8K | 4 | Oct 6, 2023 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Mar 1, 2023 | 3 | -$4.85K | 4 | Mar 3, 2023 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Feb 11, 2023 | 3 | -$24.7K | 4 | Feb 14, 2023 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Nov 8, 2022 | 3 | -$10.3K | 4 | Nov 10, 2022 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Oct 3, 2022 | 2 | $0 | 4 | Oct 5, 2022 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Aug 26, 2022 | 1 | $15.8K | 4 | Aug 30, 2022 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Feb 11, 2022 | 2 | $0 | 4 | Feb 15, 2022 | General Counsel and CCO |
OPRX | OptimizeRx Corp | Nov 8, 2021 | 2 | $0 | 4 | Nov 10, 2021 | General Counsel and CCO |